Borges L - Search Results

1

Non-invasive detection of a palifermin-mediated adaptive response following chemotherapy-induced damage to the distal small intestine of rats.

Yazbeck R, Howarth GS, Borges L, Geier MS, Smith CL, Davidson GP, Butler RN. Yazbeck R, et al. Among authors: borges l. Cancer Biol Ther. 2011 Sep 1;12(5):399-406. doi: 10.4161/cbt.12.5.15977. Epub 2011 Sep 1. Cancer Biol Ther. 2011. PMID: 21705855 Free article.

2

Effects of palifermin on antitumor activity of chemotherapeutic and biological agents in human head and neck and colorectal carcinoma xenograft models.

Brake R, Starnes C, Lu J, Chen D, Yang S, Radinsky R, Borges L. Brake R, et al. Among authors: borges l. Mol Cancer Res. 2008 Aug;6(8):1337-46. doi: 10.1158/1541-7786.MCR-07-2131. Mol Cancer Res. 2008. PMID: 18708365

3

A protective role for keratinocyte growth factor in a murine model of chemotherapy and radiotherapy-induced mucositis.

Borges L, Rex KL, Chen JN, Wei P, Kaufman S, Scully S, Pretorius JK, Farrell CL. Borges L, et al. Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):254-62. doi: 10.1016/j.ijrobp.2006.05.025. Int J Radiat Oncol Biol Phys. 2006. PMID: 16904525

4

Expression of Trop2 cell surface glycoprotein in normal and tumor tissues: potential implications as a cancer therapeutic target.

Stepan LP, Trueblood ES, Hale K, Babcook J, Borges L, Sutherland CL. Stepan LP, et al. Among authors: borges l. J Histochem Cytochem. 2011 Jul;59(7):701-10. doi: 10.1369/0022155411410430. Epub 2011 May 6. J Histochem Cytochem. 2011. PMID: 21551320 Free PMC article.

5

Generation and characterization of monoclonal antibodies to human keratinocyte growth factor receptor.

Wei P, Zhan J, Liu S, Chang D, Haldankar R, Burkhardt K, Crouse J, Hui J, Juan T, Talvenheimo J, Kim H, Li L, Boone T, Borges L. Wei P, et al. Among authors: borges l. Hybridoma (Larchmt). 2006 Jun;25(3):115-24. doi: 10.1089/hyb.2006.25.115. Hybridoma (Larchmt). 2006. PMID: 16796457

6

Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors.

Meininger D, Zalameda L, Liu Y, Stepan LP, Borges L, McCarter JD, Sutherland CL. Meininger D, et al. Among authors: borges l. Biochim Biophys Acta. 2011 Dec;1814(12):1947-54. doi: 10.1016/j.bbapap.2011.07.023. Epub 2011 Jul 31. Biochim Biophys Acta. 2011. PMID: 21835273

7

A diversity of antibody epitopes can induce signaling through the erythropoietin receptor.

Lim AC, Ketchem RR, Borges L, Carabeo T, Carter J, Hoover JE, Hu Z, Wittekind M, Zhou H, Mehlin C. Lim AC, et al. Among authors: borges l. Biochemistry. 2010 May 11;49(18):3797-804. doi: 10.1021/bi1001147. Biochemistry. 2010. PMID: 20337434

8

Cloning and characterization of rat density-enhanced phosphatase-1, a protein tyrosine phosphatase expressed by vascular cells.

Borges LG, Seifert RA, Grant FJ, Hart CE, Disteche CM, Edelhoff S, Solca FF, Lieberman MA, Lindner V, Fischer EH, Lok S, Bowen-Pope DF. Borges LG, et al. Circ Res. 1996 Sep;79(3):570-80. doi: 10.1161/01.res.79.3.570. Circ Res. 1996. PMID: 8781490

9

LIR9, an immunoglobulin-superfamily-activating receptor, is expressed as a transmembrane and as a secreted molecule.

Borges L, Kubin M, Kuhlman T. Borges L, et al. Blood. 2003 Feb 15;101(4):1484-6. doi: 10.1182/blood-2002-05-1432. Epub 2002 Sep 26. Blood. 2003. PMID: 12393390 Free article.

10

Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo.

Borges L, Miller RE, Jones J, Ariail K, Whitmore J, Fanslow W, Lynch DH. Borges L, et al. J Immunol. 1999 Aug 1;163(3):1289-97. J Immunol. 1999. PMID: 10415026

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

782 results

Search Page

Filters